I just claimed my .agent domain and joined the .agent community! get yours now and help shape the future of autonomous agents https://t.co/dxlPHZWbDo @agentcommunity_
@Im_Specter@Frederi55284379 Le space le reconnaît comme étant un clown. Tout le monde se fou de sa gueule en off, c'est assez fou. Il est très solide mentalement ceci dit d'être autant raillé et de continuer son compte.
🚨 BREAKING: Someone just open-sourced software that sees you through walls using only WIFI signals.
it’s called WiFi-DensePose. It maps your exact body pose in real-time. no cameras. no sensors. just your living room router.
100% Open Source.
Teradyne just printed insane numbers.
I’ve been invested since ~$75 and flagged it nearly a year ago around $70.
Now trading near $300 !!!!!
This is what happens when you sit tight in high-quality names.
Robotics exposure, real earnings, real execution.
Summary of the $EQR.AX call:
Iolanthe reached, feed to begin hitting the plant in 3rd week of Feb.
Expansion of Mt Carbine processing plant to begin in November, pending some external funding discussions.
Drilling program to begin in June quarter at Saloro and Carbine to expand the resources.
Exploration of old tungsten mines around Saloro and Mt Carbine (Wolfram Camp) and looking at joint ventures with others who hold similar tenements nearby to Carbine.
Looking at a NASDAQ listing but it isn’t a simple exercise or a priority at the moment.
Business is derisked from a financial perspective and looking forward to getting the plant and business fundamentals stronger throughout the year.
See the full thread attached:
BREAKING: Gokce Guven, the 26-year-old founder of fintech startup Kalder and Forbes 2025 30 Under 30 honoree, faces up to 52 years in prison for an alleged $7 million fraud.
Nordea cuts its target price on $NVO to DKK 486 from DKK 520 ahead of next week’s earnings, but reiterates Buy.
Focus is on 2026 guidance, where Nordea expects headwinds from lower prices and rising competition, including Eli Lilly’s oral GLP-1 (Orforglipron) expected in April. While the Wegovy pill launch in the U.S. has started well, Nordea forecasts a 2–6% sales decline in 2026 and operating profit growth of 2–8%, below current consensus.
#StocksToBuy #Investor
🔴Central banks are reducing their balance sheets at a HISTORIC PACE:
The Fed’s total assets-to-GDP ratio has fallen 13 percentage points in 3 years, to 22%, matching 2013 levels.
Central banks in the Euro Area and the UK have unwound their pandemic-era QE relative to GDP.